Black Rock Inc. Synaptogenix, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Synaptogenix, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 732 shares of SNPX stock, worth $3,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
732
Previous 942
22.29%
Holding current value
$3,330
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SNPX
# of Institutions
25Shares Held
955KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny401KShares$1.83 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA154KShares$702,8430.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il83.5KShares$380,1250.0% of portfolio
-
Two Sigma Securities, LLC New York, NY83.4KShares$379,5100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA68.5KShares$311,7750.0% of portfolio
About Synaptogenix, Inc.
- Ticker SNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 6,840,630
- Market Cap $31.1M
- Description
- Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...